ENSG00000085224 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000085224 ATRX -0.4 5.24e-13 KIRC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000085224 ATRX tumor 10766351
ENSG00000085224 ATRX cancer 11555636
ENSG00000085224 ATRX prostate tumors 16847812
ENSG00000085224 ATRX AML 16914901
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 21252315
ENSG00000085224 ATRX tumors 21719641
ENSG00000085224 ATRX neuroendocrine tumors 22251937
ENSG00000085224 ATRX tumours 22286061
ENSG00000085224 ATRX tumour 22315652
ENSG00000085224 ATRX tumors 22416102
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 22575867
ENSG00000085224 ATRX tumors 22661320
ENSG00000085224 ATRX tumours 22771539
ENSG00000085224 ATRX tumors 22829774
ENSG00000085224 ATRX tumors 22869205
ENSG00000085224 ATRX astrocytic tumors 22886134
ENSG00000085224 ATRX tumor 23104868
ENSG00000085224 ATRX tumors 23185534
ENSG00000085224 ATRX tumors 23202128
ENSG00000085224 ATRX tumor 23249563
ENSG00000085224 ATRX cancers 23284920
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 23361940
ENSG00000085224 ATRX tumors 23391111
ENSG00000085224 ATRX astrocytic tumors 23417712
ENSG00000085224 ATRX tumors 23429284
ENSG00000085224 ATRX tumour 23429748
ENSG00000085224 ATRX cancer 23444137
ENSG00000085224 ATRX tumors 23530248
ENSG00000085224 ATRX cancer 23563309
ENSG00000085224 ATRX tumors 23583981
ENSG00000085224 ATRX tumor 23708087
ENSG00000085224 ATRX GBM 23760585
ENSG00000085224 ATRX tumors 23765250
ENSG00000085224 ATRX astrocytic tumors 23904111
ENSG00000085224 ATRX GBM 23906214
ENSG00000085224 ATRX tumor 23954140
ENSG00000085224 ATRX GBMs 24140581
ENSG00000085224 ATRX tumor 24147068
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 24148618
ENSG00000085224 ATRX Tumors 24202337
ENSG00000085224 ATRX tumor 24336570
ENSG00000085224 ATRX tumors 24413054
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 24436263
ENSG00000085224 ATRX GBMs 24445767
ENSG00000085224 ATRX tumors 24500201
ENSG00000085224 ATRX tumors 24559763
ENSG00000085224 ATRX cancer 24563217
ENSG00000085224 ATRX tumors 24622842
ENSG00000085224 ATRX tumours 24651726
ENSG00000085224 ATRX tumors 24703847
ENSG00000085224 ATRX tumors 24716189
ENSG00000085224 ATRX tumors 24792489
ENSG00000085224 ATRX tumors 24810474
ENSG00000085224 ATRX cancers 24834375
ENSG00000085224 ATRX GBM 24843883
ENSG00000085224 ATRX cancers 25045581
ENSG00000085224 ATRX tumor 25077701
ENSG00000085224 ATRX cancer 25092303
ENSG00000085224 ATRX tumors 25161957
ENSG00000085224 ATRX tumors 25182241
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 25210493
ENSG00000085224 ATRX tumors 25227228
ENSG00000085224 ATRX tumors 25229770
ENSG00000085224 ATRX tumors 25257301
ENSG00000085224 ATRX GBM 25304031
ENSG00000085224 ATRX tumors 25427834
ENSG00000085224 ATRX tumor 25439321
ENSG00000085224 ATRX GBMs 25461780
ENSG00000085224 ATRX tumor 25467309
ENSG00000085224 ATRX GBMs 25479829
ENSG00000085224 ATRX tumor 25484917
ENSG00000085224 ATRX tumors 25487495
ENSG00000085224 ATRX cancers 25593184
ENSG00000085224 ATRX cancers 25608029
ENSG00000085224 ATRX tumor 25618849
ENSG00000085224 ATRX tumors 25639868
ENSG00000085224 ATRX GBMs 25646073
ENSG00000085224 ATRX oligodendroglial tumors 25664944
ENSG00000085224 ATRX tumors 25668564
ENSG00000085224 ATRX cancers 25690891
ENSG00000085224 ATRX tumor 25722939
ENSG00000085224 ATRX tumors 25743702
ENSG00000085224 ATRX tumors 25773741
ENSG00000085224 ATRX tumors 25785247
ENSG00000085224 ATRX cancer 25788983
ENSG00000085224 ATRX cancer 25803170
ENSG00000085224 ATRX GBM 25821160
ENSG00000085224 ATRX tumors 25853694
ENSG00000085224 ATRX cancers 25865896
ENSG00000085224 ATRX tumor 25943885
ENSG00000085224 ATRX astrocytic tumors 25971279
ENSG00000085224 ATRX breast cancers 25994018
ENSG00000085224 ATRX tumors 26001292
ENSG00000085224 ATRX GBMs 26004297
ENSG00000085224 ATRX Tumor 26014050
ENSG00000085224 ATRX tumours 26016385
ENSG00000085224 ATRX tumors 26022452
ENSG00000085224 ATRX tumors 26026117
ENSG00000085224 ATRX cancer 26055325
ENSG00000085224 ATRX cancer 26087898
ENSG00000085224 ATRX tumours 26143912
ENSG00000085224 ATRX malignant vascular tumors 26190196
ENSG00000085224 ATRX tumors 26210286
ENSG00000085224 ATRX tumors 26244119
ENSG00000085224 ATRX GBM 26253838
ENSG00000085224 ATRX malignant peripheral nerve sheath tumours 26291601
ENSG00000085224 ATRX cancers 26304540
ENSG00000085224 ATRX GBMs 26323991
ENSG00000085224 ATRX tumors 26355235
ENSG00000085224 ATRX tumors 26369702
ENSG00000085224 ATRX Cancer 26373274
ENSG00000085224 ATRX Cancer 26373281
ENSG00000085224 ATRX Tumors 26395639
ENSG00000085224 ATRX GBM 26427041
ENSG00000085224 ATRX tumors 26428317
ENSG00000085224 ATRX tumour 26466568
ENSG00000085224 ATRX tumors 26545048
ENSG00000085224 ATRX tumors 26556853
ENSG00000085224 ATRX tumours 26632267
ENSG00000085224 ATRX cancer 26646632
ENSG00000085224 ATRX tumor 26678657
ENSG00000085224 ATRX cancer 26692951
ENSG00000085224 ATRX cancer 26697514
ENSG00000085224 ATRX tumor 26699864
ENSG00000085224 ATRX tumour 26741321
ENSG00000085224 ATRX tumor 26753123
ENSG00000085224 ATRX cancers 26773061
ENSG00000085224 ATRX tumors 26794043
ENSG00000085224 ATRX Tumor 26817999
ENSG00000085224 ATRX GBMs 26833422
ENSG00000085224 ATRX tumors 26853339
ENSG00000085224 ATRX GBMs 26879021
ENSG00000085224 ATRX tumor 26891131
ENSG00000085224 ATRX tumor 26905832
ENSG00000085224 ATRX tumors 26910568
ENSG00000085224 ATRX tumors 26918938
ENSG00000085224 ATRX tumor 26936505
ENSG00000085224 ATRX tumors 27001774
ENSG00000085224 ATRX cancer 27009842
ENSG00000085224 ATRX cancers 27029610
ENSG00000085224 ATRX tumor 27036230
ENSG00000085224 ATRX tumors 27162024
ENSG00000085224 ATRX cancer 27171262
ENSG00000085224 ATRX tumor 27209355
ENSG00000085224 ATRX tumor 27267993
ENSG00000085224 ATRX tumors 27282637
ENSG00000085224 ATRX tumors 27311324
ENSG00000085224 ATRX cancer 27323951
ENSG00000085224 ATRX tumors 27342911
ENSG00000085224 ATRX Pancreatic Neuroendocrine Tumors 27407094
ENSG00000085224 ATRX tumors 27411289
ENSG00000085224 ATRX tumors 27418145
ENSG00000085224 ATRX astrocytic tumors 27425854
ENSG00000085224 ATRX tumors 27469217
ENSG00000085224 ATRX tumours 27499896
ENSG00000085224 ATRX oligodendroglial tumors 27556304
ENSG00000085224 ATRX cancer 27578458
ENSG00000085224 ATRX GBM 27579614
ENSG00000085224 ATRX tumors 27585244
ENSG00000085224 ATRX cancers 27590521
ENSG00000085224 ATRX tumors 27604789
ENSG00000085224 ATRX tumors 27657132
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 27663587
ENSG00000085224 ATRX tumors 27698411
ENSG00000085224 ATRX astrocytic tumors 27713914
ENSG00000085224 ATRX tumors 27758882
ENSG00000085224 ATRX tumor 27788029
ENSG00000085224 ATRX oligodendroglial tumor 27796734
ENSG00000085224 ATRX tumors 27799281
ENSG00000085224 ATRX tumor 27852048
ENSG00000085224 ATRX cancers 27869828
ENSG00000085224 ATRX tumors 27994516
ENSG00000085224 ATRX tumors 27997549
ENSG00000085224 ATRX tumor 28030632
ENSG00000085224 ATRX tumors 28040793
ENSG00000085224 ATRX cancer 28042953
ENSG00000085224 ATRX tumors 28055978
ENSG00000085224 ATRX pediatric tumors 28062559
ENSG00000085224 ATRX tumor 28115389
ENSG00000085224 ATRX tumors 28135248
ENSG00000085224 ATRX cancers 28183782
ENSG00000085224 ATRX tumor 28210673
ENSG00000085224 ATRX tumor 28251430
ENSG00000085224 ATRX tumor 28255664
ENSG00000085224 ATRX tumours 28284043
ENSG00000085224 ATRX brain tumors 28303493
ENSG00000085224 ATRX brain tumors 28371217
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 28371511
ENSG00000085224 ATRX CNS tumor 28392842
ENSG00000085224 ATRX cervical cancer 28395727
ENSG00000085224 ATRX tumors 28451993
ENSG00000085224 ATRX tumors 28452859
ENSG00000085224 ATRX tumors 28454119
ENSG00000085224 ATRX tumours 28484589
ENSG00000085224 ATRX tumours 28487353
ENSG00000085224 ATRX brain tumor 28488024
ENSG00000085224 ATRX GBM 28497778
ENSG00000085224 ATRX tumor 28513547
ENSG00000085224 ATRX tumor 28546523
ENSG00000085224 ATRX tumor 28591701
ENSG00000085224 ATRX tumor 28597868
ENSG00000085224 ATRX tumours 28654422
ENSG00000085224 ATRX tumor 28695151
ENSG00000085224 ATRX tumor 28696020
ENSG00000085224 ATRX tumor 28699883
ENSG00000085224 ATRX Cancer 28710315
ENSG00000085224 ATRX tumors 28718400
ENSG00000085224 ATRX Neuroendocrine Tumors 28719461
ENSG00000085224 ATRX cancers 28741530
ENSG00000085224 ATRX tumours 28796347
ENSG00000085224 ATRX tumors 28823044
ENSG00000085224 ATRX cancer 28851357
ENSG00000085224 ATRX GBMs 28851427
ENSG00000085224 ATRX cancer 28855512
ENSG00000085224 ATRX tumor 28877067
ENSG00000085224 ATRX cancer 28883432
ENSG00000085224 ATRX tumours 28955830
ENSG00000085224 ATRX GBMs 28958143
ENSG00000085224 ATRX GBM 28966033
ENSG00000085224 ATRX tumors 28979716
ENSG00000085224 ATRX tumor 28993028
ENSG00000085224 ATRX Tumours 29026176
ENSG00000085224 ATRX tumors 29027701
ENSG00000085224 ATRX tumors 29034211
ENSG00000085224 ATRX astrocytic tumors 29050070
ENSG00000085224 ATRX tumours 29053887
ENSG00000085224 ATRX tumors 29084603
ENSG00000085224 ATRX Tumors 29084956
ENSG00000085224 ATRX tumours 29098416
ENSG00000085224 ATRX tumour 29099032
ENSG00000085224 ATRX tumors 29107533
ENSG00000085224 ATRX neuroendocrine tumors 29144820
ENSG00000085224 ATRX tumors 29156578
ENSG00000085224 ATRX tumors 29163774
ENSG00000085224 ATRX AML 29196926
ENSG00000085224 ATRX tumor 29212165
ENSG00000085224 ATRX tumours 29258767
ENSG00000085224 ATRX high-grade astrocytic tumor 29264735
ENSG00000085224 ATRX GBMs 29302887
ENSG00000085224 ATRX tumor 29312603
ENSG00000085224 ATRX tumours 29321190
ENSG00000085224 ATRX tumors 29321523
ENSG00000085224 ATRX GBM 29359122
ENSG00000085224 ATRX tumors 29403544
ENSG00000085224 ATRX tumours 29444910
ENSG00000085224 ATRX cancers 29463031
ENSG00000085224 ATRX cancer 29479426
ENSG00000085224 ATRX tumors 29486199
ENSG00000085224 ATRX GBM 29509313
ENSG00000085224 ATRX GBM 29521646
ENSG00000085224 ATRX tumors 29521944
ENSG00000085224 ATRX astrocytic tumors 29527387
ENSG00000085224 ATRX tumors 29535300
ENSG00000085224 ATRX Cancer 29545335
ENSG00000085224 ATRX GBM 29548052
ENSG00000085224 ATRX cancer 29550762
ENSG00000085224 ATRX tumors 29550880
ENSG00000085224 ATRX tumor 29560102
ENSG00000085224 ATRX tumor 29596894
ENSG00000085224 ATRX tumors 29600313
ENSG00000085224 ATRX tumors 29602769
ENSG00000085224 ATRX tumor 29615461
ENSG00000085224 ATRX tumor 29616301
ENSG00000085224 ATRX tumors 29631562
ENSG00000085224 ATRX tumors 29660202
ENSG00000085224 ATRX cancers 29669917
ENSG00000085224 ATRX cancer 29706636
ENSG00000085224 ATRX tumours 29718321
ENSG00000085224 ATRX tumours 29720725
ENSG00000085224 ATRX tumours 29721688
ENSG00000085224 ATRX Tumors 29727696
ENSG00000085224 ATRX tumours 29751586
ENSG00000085224 ATRX tumours 29755120
ENSG00000085224 ATRX tumor 29763623
ENSG00000085224 ATRX tumor 29776332
ENSG00000085224 ATRX tumor 29796169
ENSG00000085224 ATRX tumors 29802247
ENSG00000085224 ATRX tumors 29805974
ENSG00000085224 ATRX tumor 29846902
ENSG00000085224 ATRX cancer 29889582
ENSG00000085224 ATRX GBMs 29896287
ENSG00000085224 ATRX tumors 29937341
ENSG00000085224 ATRX cancer 29973652
ENSG00000085224 ATRX cancer 29992434
ENSG00000085224 ATRX tumor 30006355
ENSG00000085224 ATRX GBMs 30010995
ENSG00000085224 ATRX GBMs 30038102
ENSG00000085224 ATRX tumor 30062048
ENSG00000085224 ATRX cancer 30073207
ENSG00000085224 ATRX tumors 30073524
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 30081149
ENSG00000085224 ATRX cancers 30087349
ENSG00000085224 ATRX Tumor 30107580
ENSG00000085224 ATRX tumor 30192422
ENSG00000085224 ATRX tumor 30214228
ENSG00000085224 ATRX cancers 30214690
ENSG00000085224 ATRX Cancers 30226859
ENSG00000085224 ATRX tumors 30234181
ENSG00000085224 ATRX tumors 30263090
ENSG00000085224 ATRX tumor 30263940
ENSG00000085224 ATRX tumors 30279357
ENSG00000085224 ATRX tumors 30301828
ENSG00000085224 ATRX gallbladder cancer 30304546
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 30315258
ENSG00000085224 ATRX GBMs 30333046
ENSG00000085224 ATRX cancer 30341300
ENSG00000085224 ATRX tumor 30400878
ENSG00000085224 ATRX colon cancer 30405805
ENSG00000085224 ATRX cancer 30465651
ENSG00000085224 ATRX GBMs 30504574
ENSG00000085224 ATRX cancers 30510993
ENSG00000085224 ATRX tumors 30531922
ENSG00000085224 ATRX tumor 30538672
ENSG00000085224 ATRX brain tumors 30539453
ENSG00000085224 ATRX tumour 30565681
ENSG00000085224 ATRX pancreatic neuroendocrine tumors 30590707
ENSG00000085224 ATRX glial tumor 30592195
ENSG00000085224 ATRX tumor 30598078
ENSG00000085224 ATRX tumor 30611004
ENSG00000085224 ATRX Tumor 30625996
ENSG00000085224 ATRX tumors 30627226
ENSG00000085224 ATRX tumors 30654820
ENSG00000085224 ATRX tumors 30655743
ENSG00000085224 ATRX tumor 30657883
ENSG00000085224 ATRX tumors 30658672
ENSG00000085224 ATRX tumors 30738431
ENSG00000085224 ATRX cancer 30745338
ENSG00000085224 ATRX cancer 30755392
ENSG00000085224 ATRX tumors 30760578
ENSG00000085224 ATRX tumors 30760980
ENSG00000085224 ATRX tumours 30786920
ENSG00000085224 ATRX cancers 30808951
ENSG00000085224 ATRX tumors 30831644
ENSG00000085224 ATRX tumor 30833786
ENSG00000085224 ATRX cancer 30872255
ENSG00000085224 ATRX tumors 30872698
ENSG00000085224 ATRX cancer 30889380
ENSG00000085224 ATRX GBMs 30936423
ENSG00000085224 ATRX tumors 30937985
ENSG00000085224 ATRX tumours 30946477
ENSG00000085224 ATRX tumor 30957015
ENSG00000085224 ATRX tumor 30967140
ENSG00000085224 ATRX tumor 30970016
ENSG00000085224 ATRX tumor 31018240
ENSG00000085224 ATRX tumour 31018710
ENSG00000085224 ATRX cancers 31062529
ENSG00000085224 ATRX cancer 31086817
ENSG00000085224 ATRX tumors 31115468
ENSG00000085224 ATRX tumor 31124566
ENSG00000085224 ATRX tumors 31128432
ENSG00000085224 ATRX GBM 31152217
ENSG00000085224 ATRX tumor 31160355
ENSG00000085224 ATRX tumors 31200515
ENSG00000085224 ATRX tumor 31212687
ENSG00000085224 ATRX Pineal Parenchymal Tumors of Intermediate Differentiation 31225581
ENSG00000085224 ATRX tumor 31248429
ENSG00000085224 ATRX tumor 31290679
ENSG00000085224 ATRX tumors 31290759
ENSG00000085224 ATRX tumor 31311166
ENSG00000085224 ATRX cancer 31329278
ENSG00000085224 ATRX cancer 31336873
ENSG00000085224 ATRX cancer 31341965
ENSG00000085224 ATRX Cancer 31371348
ENSG00000085224 ATRX lung cancer 31374064
ENSG00000085224 ATRX tumors 31435515
ENSG00000085224 ATRX tumour 31443481
ENSG00000085224 ATRX tumor 31447390
ENSG00000085224 ATRX cancers 31454099
ENSG00000085224 ATRX tumors 31462295
ENSG00000085224 ATRX pulmonary carcinoid tumors 31499081
ENSG00000085224 ATRX cancer 31500094
ENSG00000085224 ATRX GBMs 31505839
ENSG00000085224 ATRX tumor 31520766
ENSG00000085224 ATRX cancers 31546714
ENSG00000085224 ATRX Cancers 31551363
ENSG00000085224 ATRX tumours 31555489
ENSG00000085224 ATRX Pancreatic Neuroendocrine Tumors 31599805
ENSG00000085224 ATRX tumor 31604779
ENSG00000085224 ATRX Prostate Cancer 31611308
ENSG00000085224 ATRX tumors 31647501
ENSG00000085224 ATRX tumors 31647544
ENSG00000085224 ATRX tumors 31661039
ENSG00000085224 ATRX tumors 31692857
ENSG00000085224 ATRX tumors 31706351
ENSG00000085224 ATRX cancers 31750255
ENSG00000085224 ATRX tumor 31771970
ENSG00000085224 ATRX tumor 31811342
ENSG00000085224 ATRX nonfunctioning tumors 31819132
ENSG00000085224 ATRX Cancer 31908895
ENSG00000085224 ATRX GBM 31930277
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000085224 ATRX brain glioblastoma frameshift_variant 8.355% (130/1556) 10 entries
ENSG00000085224 ATRX pancreatic neuroendocrine tumor missense_variant 13.44% (41/305) 3 entries
ENSG00000085224 ATRX brain astrocytoma stop_gained 43.75% (21/48) 1 entry
ENSG00000085224 ATRX brain glioblastoma sequence_alteration 8.355% (130/1556) 5 entries
ENSG00000085224 ATRX oligoastrocytoma sequence_alteration 48.21% (27/56) 3 entries
ENSG00000085224 ATRX colon adenocarcinoma stop_gained 8.34% (108/1295) 2 entries
ENSG00000085224 ATRX cecum adenocarcinoma sequence_alteration 11.11% (30/270) 1 entry
ENSG00000085224 ATRX leiomyosarcoma frameshift_variant 23.33% (28/120) 3 entries
ENSG00000085224 ATRX colon adenocarcinoma sequence_alteration 8.34% (108/1295) 3 entries
ENSG00000085224 ATRX anaplastic oligoastrocytoma missense_variant 46.99% (39/83) 4 entries
ENSG00000085224 ATRX oligoastrocytoma stop_gained 48.21% (27/56) 3 entries
ENSG00000085224 ATRX pancreatic neuroendocrine tumor frameshift_variant 13.44% (41/305) 3 entries
ENSG00000085224 ATRX colon adenocarcinoma frameshift_variant 8.34% (108/1295) 5 entries
ENSG00000085224 ATRX pancreatic neuroendocrine tumor stop_gained 13.44% (41/305) 3 entries
ENSG00000085224 ATRX oligoastrocytoma missense_variant 48.21% (27/56) 2 entries
ENSG00000085224 ATRX glioma missense_variant 12.2% (85/697) 1 entry
ENSG00000085224 ATRX glioma frameshift_variant 12.2% (85/697) 2 entries
ENSG00000085224 ATRX glioma stop_gained 12.2% (85/697) 2 entries
ENSG00000085224 ATRX breast ductal adenocarcinoma missense_variant 9.948% (171/1719) 2 entries
ENSG00000085224 ATRX anaplastic astrocytoma sequence_alteration 49.34% (112/227) 3 entries
ENSG00000085224 ATRX breast ductal adenocarcinoma stop_gained 9.948% (171/1719) 2 entries
ENSG00000085224 ATRX brain glioblastoma missense_variant 8.355% (130/1556) 7 entries
ENSG00000085224 ATRX anaplastic oligoastrocytoma stop_gained 46.99% (39/83) 4 entries
ENSG00000085224 ATRX anaplastic astrocytoma frameshift_variant 49.34% (112/227) 7 entries
ENSG00000085224 ATRX brain astrocytoma frameshift_variant 43.75% (21/48) 1 entry
ENSG00000085224 ATRX cecum adenocarcinoma missense_variant 11.11% (30/270) 3 entries
ENSG00000085224 ATRX HER2 Positive Breast Carcinoma missense_variant 26.09% (36/138) 1 entry
ENSG00000085224 ATRX breast ductal adenocarcinoma sequence_alteration 9.948% (171/1719) 3 entries
ENSG00000085224 ATRX oligoastrocytoma frameshift_variant 48.21% (27/56) 6 entries
ENSG00000085224 ATRX pancreatic neuroendocrine tumor sequence_alteration 13.44% (41/305) 1 entry
ENSG00000085224 ATRX brain glioblastoma stop_gained 8.355% (130/1556) 7 entries
ENSG00000085224 ATRX cecum adenocarcinoma frameshift_variant 11.11% (30/270) 3 entries
ENSG00000085224 ATRX leiomyosarcoma missense_variant 23.33% (28/120) 1 entry
ENSG00000085224 ATRX HER2 Positive Breast Carcinoma sequence_alteration 26.09% (36/138) 1 entry
ENSG00000085224 ATRX anaplastic oligoastrocytoma sequence_alteration 46.99% (39/83) 3 entries
ENSG00000085224 ATRX glioma sequence_alteration 12.2% (85/697) 1 entry
ENSG00000085224 ATRX leiomyosarcoma stop_gained 23.33% (28/120) 2 entries
ENSG00000085224 ATRX colon adenocarcinoma missense_variant 8.34% (108/1295) 11 entries
ENSG00000085224 ATRX colon adenocarcinoma conservative_inframe_deletion 8.34% (108/1295) 2 entries
ENSG00000085224 ATRX anaplastic oligoastrocytoma frameshift_variant 46.99% (39/83) 6 entries
ENSG00000085224 ATRX leiomyosarcoma sequence_alteration 23.33% (28/120) 1 entry
ENSG00000085224 ATRX brain astrocytoma sequence_alteration 43.75% (21/48) 1 entry
ENSG00000085224 ATRX anaplastic astrocytoma missense_variant 49.34% (112/227) 5 entries
ENSG00000085224 ATRX anaplastic astrocytoma stop_gained 49.34% (112/227) 8 entries
ENSG00000085224 ATRX acute myeloid leukemia stop_gained 0.8624% (24/2783) 1 entry
ENSG00000085224 ATRX undifferentiated pleomorphic sarcoma stop_gained 14.52% (9/62) 1 entry
ENSG00000085224 ATRX glioma amino_acid_insertion 12.2% (85/697) 1 entry
ENSG00000085224 ATRX clear cell renal carcinoma missense_variant 1.3% (21/1616) 4 entries
ENSG00000085224 ATRX Uterine Carcinosarcoma sequence_alteration 8.485% (14/165) 1 entry
ENSG00000085224 ATRX Cortisol-Producing Adrenal Cortex Adenoma missense_variant 1.613% (2/124) 2 entries
ENSG00000085224 ATRX skin melanoma stop_gained 4.217% (49/1162) 3 entries
ENSG00000085224 ATRX papillary renal cell carcinoma missense_variant 0.5155% (2/388) 1 entry
ENSG00000085224 ATRX lung adenocarcinoma sequence_alteration 4.551% (117/2571) 3 entries
ENSG00000085224 ATRX Uterine Carcinosarcoma missense_variant 8.485% (14/165) 2 entries
ENSG00000085224 ATRX adrenal gland pheochromocytoma missense_variant 3.136% (9/287) 2 entries
ENSG00000085224 ATRX Endometrial Endometrioid Adenocarcinoma missense_variant 4.923% (32/650) 2 entries
ENSG00000085224 ATRX breast carcinoma frameshift_variant 2.091% (35/1674) 2 entries
ENSG00000085224 ATRX Adrenal Gland Neuroblastoma missense_variant 6.818% (6/88) 1 entry
ENSG00000085224 ATRX pancreatic neuroendocrine tumor conservative_inframe_deletion 13.44% (41/305) 1 entry
ENSG00000085224 ATRX female breast carcinoma missense_variant 3.767% (11/292) 4 entries
ENSG00000085224 ATRX hemangioblastoma missense_variant 22.86% (8/35) 1 entry
ENSG00000085224 ATRX breast carcinoma conservative_inframe_deletion 2.091% (35/1674) 1 entry
ENSG00000085224 ATRX lung adenocarcinoma frameshift_variant 4.551% (117/2571) 3 entries
ENSG00000085224 ATRX hepatocellular carcinoma missense_variant 1.763% (18/1021) 2 entries
ENSG00000085224 ATRX colorectal adenocarcinoma frameshift_variant 6.924% (88/1271) 2 entries
ENSG00000085224 ATRX papillary thyroid carcinoma missense_variant 1.174% (6/511) 2 entries
ENSG00000085224 ATRX breast carcinoma missense_variant 2.091% (35/1674) 3 entries
ENSG00000085224 ATRX Adrenal Gland Neuroblastoma frameshift_variant 6.818% (6/88) 1 entry
ENSG00000085224 ATRX lung adenocarcinoma stop_gained 4.551% (117/2571) 4 entries
ENSG00000085224 ATRX Gallbladder Adenocarcinoma sequence_alteration 5.455% (9/165) 1 entry
ENSG00000085224 ATRX Merkel cell skin cancer missense_variant 4.211% (4/95) 2 entries
ENSG00000085224 ATRX small cell lung carcinoma sequence_alteration 6.321% (28/443) 2 entries
ENSG00000085224 ATRX adrenal cortex carcinoma stop_gained 3.67% (8/218) 2 entries
ENSG00000085224 ATRX basal cell carcinoma missense_variant 14.71% (10/68) 2 entries
ENSG00000085224 ATRX astrocytoma missense_variant 40.0% (6/15) 2 entries
ENSG00000085224 ATRX skin melanoma missense_variant 4.217% (49/1162) 5 entries
ENSG00000085224 ATRX small cell lung carcinoma missense_variant 6.321% (28/443) 5 entries
ENSG00000085224 ATRX melanoma missense_variant 13.01% (19/146) 3 entries
ENSG00000085224 ATRX Cervical Small Cell Carcinoma missense_variant 50.0% (4/8) 1 entry
ENSG00000085224 ATRX clear cell renal carcinoma sequence_alteration 1.3% (21/1616) 1 entry
ENSG00000085224 ATRX mucosal melanoma frameshift_variant 15.71% (11/70) 1 entry
ENSG00000085224 ATRX large cell lung carcinoma missense_variant 10.53% (2/19) 1 entry
ENSG00000085224 ATRX nasopharyngeal squamous cell carcinoma frameshift_variant 3.247% (10/308) 1 entry
ENSG00000085224 ATRX colorectal adenocarcinoma missense_variant 6.924% (88/1271) 4 entries
ENSG00000085224 ATRX brain astrocytoma missense_variant 43.75% (21/48) 1 entry
ENSG00000085224 ATRX esophageal adenocarcinoma missense_variant 1.825% (10/548) 2 entries
ENSG00000085224 ATRX colon adenocarcinoma amino_acid_insertion 8.34% (108/1295) 1 entry
ENSG00000085224 ATRX undifferentiated pleomorphic sarcoma frameshift_variant 14.52% (9/62) 1 entry
ENSG00000085224 ATRX urothelial carcinoma missense_variant 9.302% (8/86) 1 entry
ENSG00000085224 ATRX neoplasm missense_variant 7.895% (3/38) 1 entry
ENSG00000085224 ATRX osteosarcoma stop_gained 6.369% (10/157) 3 entries
ENSG00000085224 ATRX cecum adenocarcinoma conservative_inframe_deletion 11.11% (30/270) 1 entry
ENSG00000085224 ATRX pleomorphic liposarcoma frameshift_variant 44.44% (4/9) 2 entries
ENSG00000085224 ATRX non-small cell lung carcinoma missense_variant 5.556% (6/108) 2 entries
ENSG00000085224 ATRX small cell lung carcinoma stop_gained 6.321% (28/443) 3 entries
ENSG00000085224 ATRX chronic lymphocytic leukemia missense_variant 4.372% (39/892) 1 entry
ENSG00000085224 ATRX brain glioblastoma amino_acid_insertion 8.355% (130/1556) 1 entry
ENSG00000085224 ATRX Gallbladder Adenocarcinoma missense_variant 5.455% (9/165) 3 entries
ENSG00000085224 ATRX bladder transitional cell carcinoma missense_variant 3.68% (17/462) 2 entries
ENSG00000085224 ATRX squamous cell lung carcinoma sequence_alteration 2.146% (20/932) 1 entry
ENSG00000085224 ATRX bladder transitional cell carcinoma frameshift_variant 3.68% (17/462) 1 entry
ENSG00000085224 ATRX Brain Stem Glioblastoma missense_variant 8.571% (6/70) 2 entries
ENSG00000085224 ATRX gastric adenocarcinoma missense_variant 2.973% (25/841) 5 entries
ENSG00000085224 ATRX pancreatic ductal adenocarcinoma missense_variant 6.306% (113/1792) 3 entries
ENSG00000085224 ATRX lobular breast carcinoma missense_variant 5.435% (15/276) 2 entries
ENSG00000085224 ATRX myelodysplastic syndrome sequence_alteration 3.515% (29/825) 4 entries
ENSG00000085224 ATRX prostate adenocarcinoma conservative_inframe_deletion 3.614% (78/2158) 1 entry
ENSG00000085224 ATRX ulcerative colitis stop_gained 44.44% (4/9) 1 entry
ENSG00000085224 ATRX oral squamous cell carcinoma missense_variant 2.29% (6/262) 4 entries
ENSG00000085224 ATRX mucosal melanoma stop_gained 15.71% (11/70) 1 entry
ENSG00000085224 ATRX basal cell carcinoma stop_gained 14.71% (10/68) 1 entry
ENSG00000085224 ATRX Myelodysplastic/Myeloproliferative Neoplasm missense_variant 20.0% (3/15) 2 entries
ENSG00000085224 ATRX prostate adenocarcinoma sequence_alteration 3.614% (78/2158) 1 entry
ENSG00000085224 ATRX prostate carcinoma missense_variant 1.549% (7/452) 3 entries
ENSG00000085224 ATRX Brain Stem Glioblastoma sequence_alteration 8.571% (6/70) 2 entries
ENSG00000085224 ATRX nasopharyngeal squamous cell carcinoma missense_variant 3.247% (10/308) 3 entries
ENSG00000085224 ATRX rectal adenocarcinoma frameshift_variant 2.559% (14/547) 1 entry
ENSG00000085224 ATRX ovarian serous adenocarcinoma missense_variant 0.949% (8/843) 4 entries
ENSG00000085224 ATRX colorectal adenocarcinoma conservative_inframe_deletion 6.924% (88/1271) 2 entries
ENSG00000085224 ATRX brain glioma missense_variant 13.95% (6/43) 2 entries
ENSG00000085224 ATRX prostate adenocarcinoma missense_variant 3.614% (78/2158) 3 entries
ENSG00000085224 ATRX myelodysplastic syndrome stop_gained 3.515% (29/825) 2 entries
ENSG00000085224 ATRX Endometrial Endometrioid Adenocarcinoma stop_gained 4.923% (32/650) 2 entries
ENSG00000085224 ATRX mucosal melanoma amino_acid_insertion 15.71% (11/70) 1 entry
ENSG00000085224 ATRX acute myeloid leukemia missense_variant 0.8624% (24/2783) 3 entries
ENSG00000085224 ATRX brain astrocytoma conservative_inframe_deletion 43.75% (21/48) 1 entry
ENSG00000085224 ATRX rectal adenocarcinoma missense_variant 2.559% (14/547) 3 entries
ENSG00000085224 ATRX osteosarcoma missense_variant 6.369% (10/157) 2 entries
ENSG00000085224 ATRX Kidney Angiomyolipoma frameshift_variant 25.0% (2/8) 1 entry
ENSG00000085224 ATRX rectal adenocarcinoma stop_gained 2.559% (14/547) 1 entry
ENSG00000085224 ATRX myelodysplastic syndrome missense_variant 3.515% (29/825) 5 entries
ENSG00000085224 ATRX adrenal gland pheochromocytoma conservative_inframe_deletion 3.136% (9/287) 1 entry
ENSG00000085224 ATRX gastric intestinal type adenocarcinoma missense_variant 3.529% (3/85) 2 entries
ENSG00000085224 ATRX melanoma conservative_inframe_deletion 13.01% (19/146) 1 entry
ENSG00000085224 ATRX squamous cell lung carcinoma missense_variant 2.146% (20/932) 1 entry
ENSG00000085224 ATRX esophageal squamous cell carcinoma missense_variant 1.887% (13/689) 4 entries
ENSG00000085224 ATRX diffuse large B-cell lymphoma missense_variant 0.7143% (3/420) 2 entries
ENSG00000085224 ATRX osteosarcoma frameshift_variant 6.369% (10/157) 2 entries
ENSG00000085224 ATRX Non-Functional Pancreatic Neuroendocrine Tumor missense_variant 22.58% (7/31) 1 entry
ENSG00000085224 ATRX esophageal squamous cell carcinoma stop_gained 1.887% (13/689) 1 entry
ENSG00000085224 ATRX anaplastic oligodendroglioma missense_variant 3.974% (6/151) 2 entries
ENSG00000085224 ATRX colorectal adenocarcinoma stop_gained 6.924% (88/1271) 2 entries
ENSG00000085224 ATRX hemangioblastoma sequence_alteration 22.86% (8/35) 1 entry
ENSG00000085224 ATRX bladder carcinoma missense_variant 3.922% (22/561) 1 entry
ENSG00000085224 ATRX breast carcinoma stop_gained 2.091% (35/1674) 2 entries
ENSG00000085224 ATRX central nervous system primitive neuroectodermal neoplasm frameshift_variant 3.602% (21/583) 2 entries
ENSG00000085224 ATRX oligoastrocytoma translational_product_function_variant 48.21% (27/56) 1 entry
ENSG00000085224 ATRX astrocytoma stop_gained 40.0% (6/15) 1 entry
ENSG00000085224 ATRX female breast carcinoma sequence_alteration 3.767% (11/292) 1 entry
ENSG00000085224 ATRX breast ductal adenocarcinoma conservative_inframe_deletion 9.948% (171/1719) 1 entry
ENSG00000085224 ATRX anaplastic oligodendroglioma frameshift_variant 3.974% (6/151) 2 entries
ENSG00000085224 ATRX prostate adenocarcinoma frameshift_variant 3.614% (78/2158) 2 entries
ENSG00000085224 ATRX squamous cell lung carcinoma stop_gained 2.146% (20/932) 1 entry
ENSG00000085224 ATRX diffuse large B-cell lymphoma sequence_alteration 0.7143% (3/420) 1 entry
ENSG00000085224 ATRX lung adenocarcinoma missense_variant 4.551% (117/2571) 9 entries
ENSG00000085224 ATRX myelodysplastic syndrome frameshift_variant 3.515% (29/825) 2 entries
ENSG00000085224 ATRX colorectal adenocarcinoma sequence_alteration 6.924% (88/1271) 2 entries
ENSG00000085224 ATRX chronic myelomonocytic leukemia missense_variant 1.778% (4/225) 2 entries
ENSG00000085224 ATRX Hepatoblastoma sequence_alteration 13.33% (2/15) 1 entry
ENSG00000085224 ATRX acute lymphoblastic leukemia missense_variant 0.6231% (2/321) 2 entries
ENSG00000085224 ATRX Breast Carcinoma by Gene Expression Profile missense_variant 4.167% (4/96) 1 entry
ENSG00000085224 ATRX Non-Functional Pancreatic Neuroendocrine Tumor frameshift_variant 22.58% (7/31) 1 entry
ENSG00000085224 ATRX PEComa frameshift_variant 13.33% (2/15) 1 entry
ENSG00000085224 ATRX Adrenal Gland Neuroblastoma stop_gained 6.818% (6/88) 1 entry
ENSG00000085224 ATRX Pineocytoma sequence_alteration 33.33% (1/3) 1 entry
ENSG00000085224 ATRX diffuse gastric adenocarcinoma missense_variant 1.22% (1/82) 1 entry
ENSG00000085224 ATRX Pancreatic Acinar Cell Carcinoma missense_variant 2.941% (1/34) 1 entry
ENSG00000085224 ATRX Non-Functional Pancreatic Neuroendocrine Tumor stop_gained 22.58% (7/31) 1 entry
ENSG00000085224 ATRX kidney Wilms tumor sequence_alteration 0.303% (1/330) 1 entry
ENSG00000085224 ATRX Thymic Small Cell Carcinoma missense_variant 100.0% (1/1) 1 entry
ENSG00000085224 ATRX laryngeal squamous cell carcinoma missense_variant 2.439% (1/41) 1 entry
ENSG00000085224 ATRX urothelial carcinoma stop_gained 9.302% (8/86) 1 entry
ENSG00000085224 ATRX soft tissue sarcoma missense_variant 1.02% (3/294) 1 entry
ENSG00000085224 ATRX urothelial carcinoma frameshift_variant 9.302% (8/86) 1 entry
ENSG00000085224 ATRX astrocytoma sequence_alteration 40.0% (6/15) 1 entry
ENSG00000085224 ATRX chondrosarcoma frameshift_variant 7.692% (1/13) 1 entry
ENSG00000085224 ATRX PEComa stop_gained 13.33% (2/15) 1 entry
ENSG00000085224 ATRX Ampulla of Vater Carcinoma frameshift_variant 1.176% (1/85) 1 entry
ENSG00000085224 ATRX Peritoneal Well Differentiated Papillary Mesothelioma missense_variant 10.0% (1/10) 1 entry
ENSG00000085224 ATRX bronchoalveolar adenocarcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000085224 ATRX mixed neuronal-glial tumor stop_gained 11.11% (1/9) 1 entry
ENSG00000085224 ATRX prostate adenocarcinoma stop_gained 3.614% (78/2158) 1 entry
ENSG00000085224 ATRX salivary gland carcinoma frameshift_variant 3.03% (1/33) 1 entry
ENSG00000085224 ATRX nasal cavity and paranasal sinus carcinoma missense_variant 8.696% (2/23) 1 entry
ENSG00000085224 ATRX pleomorphic liposarcoma stop_gained 44.44% (4/9) 1 entry
ENSG00000085224 ATRX Ovarian Small Cell Carcinoma sequence_alteration 6.667% (1/15) 1 entry
ENSG00000085224 ATRX Cervical Clear Cell Adenocarcinoma stop_gained 100.0% (1/1) 1 entry
ENSG00000085224 ATRX Mantle cell lymphoma missense_variant 1.493% (1/67) 1 entry
ENSG00000085224 ATRX Gastric Neuroendocrine Tumor G1 frameshift_variant 9.091% (1/11) 1 entry
ENSG00000085224 ATRX papillary thyroid carcinoma frameshift_variant 1.174% (6/511) 1 entry
ENSG00000085224 ATRX angiosarcoma stop_gained 4.167% (2/48) 1 entry
ENSG00000085224 ATRX astrocytoma conservative_inframe_deletion 40.0% (6/15) 1 entry
ENSG00000085224 ATRX Dysplasia in Ulcerative Colitis stop_gained 12.5% (1/8) 1 entry
ENSG00000085224 ATRX mucosal melanoma missense_variant 15.71% (11/70) 1 entry
ENSG00000085224 ATRX head and neck squamous cell carcinoma missense_variant 0.4005% (3/749) 1 entry
ENSG00000085224 ATRX colon carcinoma conservative_inframe_deletion 12.5% (1/8) 1 entry
ENSG00000085224 ATRX Vaginal Squamous Cell Carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000085224 ATRX Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 0.7576% (2/264) 1 entry
ENSG00000085224 ATRX undifferentiated pleomorphic sarcoma sequence_alteration 14.52% (9/62) 1 entry
ENSG00000085224 ATRX Non-Functional Pancreatic Neuroendocrine Tumor sequence_alteration 22.58% (7/31) 1 entry
ENSG00000085224 ATRX ovarian clear cell adenocarcinoma missense_variant 3.03% (1/33) 1 entry
ENSG00000085224 ATRX Mediastinal Neuroblastoma missense_variant 20.0% (1/5) 1 entry
ENSG00000085224 ATRX female breast carcinoma frameshift_variant 3.767% (11/292) 1 entry
ENSG00000085224 ATRX ulcerative colitis missense_variant 44.44% (4/9) 1 entry
ENSG00000085224 ATRX lobular breast carcinoma stop_gained 5.435% (15/276) 1 entry
ENSG00000085224 ATRX neoplasm of mature B-cells missense_variant 1.538% (1/65) 1 entry
ENSG00000085224 ATRX undifferentiated pleomorphic sarcoma conservative_inframe_deletion 14.52% (9/62) 1 entry
ENSG00000085224 ATRX brain glioma frameshift_variant 13.95% (6/43) 1 entry
ENSG00000085224 ATRX mesenchymal chondrosarcoma stop_gained 33.33% (1/3) 1 entry
ENSG00000085224 ATRX nasal cavity and paranasal sinus carcinoma stop_gained 8.696% (2/23) 1 entry
ENSG00000085224 ATRX undifferentiated pleomorphic sarcoma missense_variant 14.52% (9/62) 1 entry
ENSG00000085224 ATRX oligodendroglioma stop_gained 25.0% (1/4) 1 entry
ENSG00000085224 ATRX Adrenal Gland Neuroblastoma sequence_alteration 6.818% (6/88) 1 entry
ENSG00000085224 ATRX Anal Squamous Cell Carcinoma missense_variant 1.205% (1/83) 1 entry
ENSG00000085224 ATRX rhabdomyosarcoma sequence_alteration 2.778% (1/36) 1 entry
ENSG00000085224 ATRX Parotid Gland Adenoid Cystic Carcinoma missense_variant 7.692% (1/13) 1 entry
ENSG00000085224 ATRX choroid plexus carcinoma missense_variant 20.0% (1/5) 1 entry
ENSG00000085224 ATRX Gastrointestinal stromal tumor missense_variant 0.6579% (1/152) 1 entry
ENSG00000085224 ATRX head and neck squamous cell carcinoma conservative_inframe_deletion 0.4005% (3/749) 1 entry
ENSG00000085224 ATRX adrenal gland pheochromocytoma frameshift_variant 3.136% (9/287) 1 entry
ENSG00000085224 ATRX bone osteosarcoma missense_variant 33.33% (1/3) 1 entry
ENSG00000085224 ATRX chromophobe renal cell carcinoma missense_variant 0.6757% (1/148) 1 entry
ENSG00000085224 ATRX extra-adrenal sympathetic paraganglioma stop_gained 50.0% (1/2) 1 entry
ENSG00000085224 ATRX Benign Adrenal Gland Pheochromocytoma frameshift_variant 3.636% (2/55) 1 entry
ENSG00000085224 ATRX skin melanoma sequence_alteration 4.217% (49/1162) 1 entry
ENSG00000085224 ATRX basal cell carcinoma sequence_alteration 14.71% (10/68) 1 entry
ENSG00000085224 ATRX Spinal Cord Astrocytoma stop_gained 25.0% (1/4) 1 entry
ENSG00000085224 ATRX Duodenal Adenocarcinoma missense_variant 5.882% (1/17) 1 entry
ENSG00000085224 ATRX B-cell acute lymphoblastic leukemia stop_gained 0.8929% (1/112) 1 entry
ENSG00000085224 ATRX Bladder Adenocarcinoma frameshift_variant 14.29% (1/7) 1 entry
ENSG00000085224 ATRX soft tissue sarcoma frameshift_variant 1.02% (3/294) 1 entry
ENSG00000085224 ATRX Merkel cell skin cancer sequence_alteration 4.211% (4/95) 1 entry
ENSG00000085224 ATRX gastric adenocarcinoma frameshift_variant 2.973% (25/841) 1 entry
ENSG00000085224 ATRX Conjunctival Melanoma stop_gained 25.0% (1/4) 1 entry
ENSG00000085224 ATRX Vulvar Squamous Cell Carcinoma stop_gained 5.263% (1/19) 1 entry
ENSG00000085224 ATRX skin melanoma frameshift_variant 4.217% (49/1162) 1 entry
ENSG00000085224 ATRX follicular thyroid carcinoma missense_variant 1.429% (1/70) 1 entry
ENSG00000085224 ATRX angiosarcoma frameshift_variant 4.167% (2/48) 1 entry
ENSG00000085224 ATRX adrenal cortex carcinoma conservative_inframe_deletion 3.67% (8/218) 1 entry
ENSG00000085224 ATRX hepatocellular carcinoma frameshift_variant 1.763% (18/1021) 1 entry
ENSG00000085224 ATRX renal carcinoma missense_variant 5.0% (1/20) 1 entry
ENSG00000085224 ATRX head and neck squamous cell carcinoma sequence_alteration 0.4005% (3/749) 1 entry
ENSG00000085224 ATRX renal cell carcinoma missense_variant 1.471% (1/68) 1 entry
ENSG00000085224 ATRX ovarian serous adenocarcinoma stop_gained 0.949% (8/843) 1 entry
ENSG00000085224 ATRX Thyroid Gland Undifferentiated (Anaplastic) Carcinoma sequence_alteration 0.7576% (2/264) 1 entry
ENSG00000085224 ATRX Benign Adrenal Gland Pheochromocytoma sequence_alteration 3.636% (2/55) 1 entry
ENSG00000085224 ATRX mucosal melanoma sequence_alteration 15.71% (11/70) 1 entry
ENSG00000085224 ATRX osteosarcoma sequence_alteration 6.369% (10/157) 1 entry
ENSG00000085224 ATRX adrenal cortex carcinoma missense_variant 3.67% (8/218) 1 entry
ENSG00000085224 ATRX adrenal cortex carcinoma frameshift_variant 3.67% (8/218) 1 entry
ENSG00000085224 ATRX lung PEComa stop_gained 100.0% (1/1) 1 entry
ENSG00000085224 ATRX ovarian serous adenocarcinoma frameshift_variant 0.949% (8/843) 1 entry
ENSG00000085224 ATRX melanoma stop_gained 13.01% (19/146) 1 entry
ENSG00000085224 ATRX Brain Stem Glioblastoma frameshift_variant 8.571% (6/70) 1 entry
ENSG00000085224 ATRX oral squamous cell carcinoma sequence_alteration 2.29% (6/262) 1 entry
ENSG00000085224 ATRX Cervical Small Cell Carcinoma stop_gained 50.0% (4/8) 1 entry
ENSG00000085224 ATRX Appendix Adenocarcinoma missense_variant 1.351% (1/74) 1 entry
ENSG00000085224 ATRX anaplastic oligodendroglioma sequence_alteration 3.974% (6/151) 1 entry
ENSG00000085224 ATRX soft tissue sarcoma stop_gained 1.02% (3/294) 1 entry
ENSG00000085224 ATRX melanoma sequence_alteration 13.01% (19/146) 1 entry
ENSG00000085224 ATRX adrenocortical adenoma stop_gained 2.439% (1/41) 1 entry
ENSG00000085224 ATRX pleomorphic liposarcoma missense_variant 44.44% (4/9) 1 entry
ENSG00000085224 ATRX primary peritoneal carcinoma (disease) frameshift_variant 100.0% (1/1) 1 entry
ENSG00000085224 ATRX meningioma (disease) missense_variant 1.37% (1/73) 1 entry
ENSG00000085224 ATRX adrenal cortex carcinoma sequence_alteration 3.67% (8/218) 1 entry
ENSG00000085224 ATRX pharyngeal squamous cell carcinoma missense_variant 0.6993% (1/143) 1 entry
ENSG00000085224 ATRX rectal adenocarcinoma sequence_alteration 2.559% (14/547) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000085224 ATRX MESO 0.012 low
ENSG00000085224 ATRX UCEC 0.026 high
ENSG00000085224 ATRX THCA 0.017 high
ENSG00000085224 ATRX ACC 0.037 low
ENSG00000085224 ATRX LGG 0.0055 high
ENSG00000085224 ATRX LUSC 0.018 low
ENSG00000085224 ATRX READ 0.023 low
ENSG00000085224 ATRX KICH 0.0036 high
ENSG00000085224 ATRX BRCA 0.025 high
ENSG00000085224 ATRX ESCA 0.006 high
ENSG00000085224 ATRX OV 0.043 low
ENSG00000085224 ATRX PRAD 0.03 high
ENSG00000085224 ATRX BLCA 0.039 low
ENSG00000085224 ATRX LIHC 0.0015 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency